News

A political scientist and expert in research policy, Tim Flink plans to enhance collaboration, align research with industry needs, and strengthen our societal and political relevance.

Researchers at the Experimental and Clinical Research Center of Max Delbrück Center and Charité – Universitätsmedizin Berlin have found that microbial communities in the mouse GI tract are unevenly distributed, which influences immune cell populations. The work was published in “Gut Microbes.”

Coffee after 2 p.m. is a must — this was the motivation that drove plans for a new café on the Berlin-Buch campus. Professor Holger Gerhardt has been involved in the project from the start. We up him at the café not long after its opening.

Misha Kudryashev’s lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression and schizophrenia. Published in “The EMBO Journal,” the study points to a potentially new target for therapeutics.

Johannes Huppa has taken up the professorship for tumor immunology at Charité – Universitätsmedizin Berlin as of September 1. The T-cell receptor expert will also conduct research at the Max Delbrück Center in Berlin-Buch and the German Consortium for Translational Cancer Research (DKTK).

A team in the labs of Holger Gerhardt and Norbert Hübner at the Max Delbrück Center has elucidated how new arteries form, potentially helping to improve therapies aimed at regenerating heart muscle after a heart attack or stroke. The research was published in “Circulation Research.”

Rosalba Olga Proce is a fourth year PhD student in the Hörnberg lab. She studies the molecular basis of social behavior in mice. She is also a PhD representative and enjoys organizing community events, such as the PhD retreat. Her book recommendation transports readers into a fantasy world.

We can learn from failure, yet often we hide our setbacks, especially in our professional lives. At the next SPARK event on September 5, enjoy a piano and violin concert followed by an invigorating discussion between musicians and scientists as they explore the concept of “A CV of failures.”

Helmholtz is aiming to become climate-neutral by 2035; construction and building are critical levers in achieving this goal. The “Helmholtz Climate-Friendly Construction” Expertise Network, based at the Max Delbrück Center, aims to make a significant contribution. An interview with Christian Langfeld.

Researchers in Berlin and Düsseldorf have implicated a new gene in the progression of Huntington’s disease in a brain organoid model. The gene may contribute to brain abnormalities much earlier than previously thought. The study was published in “Nature Communications.”